Aktie A2PMPH SONOMA PHARMACEUTICALS, INC.
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen Sonoma Pharmaceuticals, Inc.

Aktien

A2PMPH

US83558L2043

SNOA

Markt geschlossen - Nasdaq
Andere Börsenplätze
 22:30:01 26.04.2024 		% 5 Tage % 1. Jan.
0.159 USD -0.87% Intraday Chart für Sonoma Pharmaceuticals, Inc. +6.00% -11.86%
08.02. Sonoma Pharmaceuticals, Inc. meldet Ergebnis für das dritte Quartal und die neun Monate bis zum 31. Dezember 2023 CI
23.01. Sonoma Pharmaceuticals bringt Lumacyn Clarifying Mist auf den Markt, ein natürliches, rezeptfreies Hautpflegeprodukt für die tägliche Anwendung CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
Sonoma Pharmaceuticals Announces Expansion of Negative-Pressure Wound Therapy Products for Use in the United States
Sonoma Pharmaceuticals Reports Recent Publication from Australia Highlighting Potential for Microdox in Managing Urinary Tract Infections
Sonoma Pharmaceuticals Highlights Safety Advantages of its Microcyn Products in Light of Growing Concerns of Benzene in Many Other Topicals
Sonoma Pharmaceuticals Reports Third Fiscal Quarter 2024 Financial Results
Sonoma Pharmaceuticals, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023
Sonoma Pharmaceuticals Introduces Lumacyn Clarifying Mist, an All Natural, Over-The-Counter Skincare Product for Daily Use
NovaBay Pharmaceuticals and Sonoma Pharmaceuticals Agree to Market Avenova-branded Products in the European Union through Sonoma's Extensive Distributor Network
NovaBay Pharmaceuticals and Sonoma Pharmaceuticals Agree to Market Avenova-branded Products in the European Union Through Sonoma?s Extensive Distributor Network
Sonoma Pharmaceuticals : Material Agreement - Form 8-K
Sonoma Pharmaceuticals, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023
Sonoma Pharmaceuticals, Inc. Announces U.S. Launch of Next Generation Advanced Solution for Pulse Lavage Irrigation At the Symposium on Advanced Wound Care Fall Conference
Sector Update: Health Care Stocks Ease in Late Afternoon
Sector Update: Health Care
Top MIdday Decliners
Wall Street Set to Open Lower as GDP, Jobless Claims Higher Than Expected
Sonoma Pharmaceuticals : Investor Presentation October 2023 - Form 8-K
National Eczema Association Awards Seal of Acceptance to Sonoma Pharmaceuticals for Reliefacyn Advanced
National Eczema Association Awards Seal of Acceptance to Sonoma Pharmaceuticals, Inc. for Reliefacyn Advanced
Sonoma Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended June 30, 2023
Sonoma Pharmaceuticals, Inc. Announces Appointment of Hye Jin Chung to Scientific Advisory Board
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A2PMPH Aktie
  4. Nachrichten Sonoma Pharmaceuticals, Inc.
  5. Andere Sprachen